Abstract. Numerous studies have demonstrated that fluid shear stress (FSS) may promote the proliferation and differentiation of osteoblast cells. However, proliferation and differentiation are mutually exclusive processes and are unlikely to be promoted by FSS simultaneously. Cell proliferation and differentiation induced by FSS has rarely been reported. In order to provide an insight into this process, the present study investigated the effects of FSS on osteoblast-like MC3T3 cells in the G0/G1 phase, the period during which the fate of a cell is determined. The results of the present study demonstrated that FSS promoted alkaline phosphatase (ALP) activity, and the mRNA expression and protein expression of osteocalcin, collagen type I and runt-related transcription factor 2 (Runx2), while inhibiting DNA synthesis and arresting the cell cycle at the G0/G1 phase. The increase in Runx2 and ALP activity was accompanied by the activation of calcium/calmodulin-dependent protein kinase type II (CaMK II) and extracellular signal-regulated kinases 1/2 (ERK1/2), which was completely abolished by treatment with KN93 and U0126, respectively. In addition, the inhibition of ERK1/2, although not CaMK II, decreased p21
Introduction
Fluid shear stress (FSS), which is generated by fluid flow inside the lacunar-canalicular networks and trabecular spaces within bone tissue, is important for the maintenance of skeletal architectural integrity (1, 2) . Previous studies have demonstrated that FSS may promote the proliferation and differentiation of osteoblasts (3) (4) (5) . The cells used in the literature are at various stages of the cell cycle rather than in a single phase, thus the effect of FSS on osteoblasts in the G0/G1 phase remains unclear. Proliferation and differentiation are exclusive physiological processes in cells and may not be simultaneously induced by FSS in a single cell. It is therefore necessary to elucidate precisely how the proliferation and differentiation of osteoblasts are regulated by FSS.
The associated events in the G0/G1 phase for a cell determine its fate with regards to proliferation or differentiation. Restriction point passage, which promotes cell cycle progression and S phase entry, is essential to drive cell proliferation, whereas cells which do not pass the restriction point may return to the G0/G1 phase in quiescence or may differentiate (6) . The product of the retinoblastoma-associated protein gene (Rb) has been reported to be an important regulatory factor in restriction point passage (7) . The phosphorylation of Rb, induced by cyclin-dependent kinases 4/6 (CDK4/6) and further activated by CDK2, promotes cell passage through the restriction point and S phase entry (8) . Dephosphorylated Rb acts as a transcriptional coactivator required for runt-related transcription factor 2 (Runx2) activity and osteogenic differentiation (9, 10) . These previous results indicated that the extent of phosphorylation of phosphorylated (p)Rb may determine the initiation of proliferation or differentiation in cells. Therefore, the present study sought to investigate how G0/G1 phase osteoblasts responded to FSS and whether pRb was involved.
Fluid shear stress induces osteoblast differentiation and arrests the cell cycle at the G0 phase via the ERK1/2 pathway
The release of intracellular Ca 2+ , activation of extracellular signal regulated kinases 1/2 (ERK1/2), and Rho signaling have been implicated in the process of osteoblast proliferation and differentiation induced by FSS (11) (12) (13) (14) (15) (16) (17) (18) . Ca 2+ is a universal intracellular secondary messenger. The blockade of Ca 2+ signaling was demonstrated to completely inhibit FSS-induced osteoblast proliferation and differentiation (4) . It has been demonstrated that the ubiquitously-expressed calcium/calmodulin-dependent protein kinase type II (CaMK II), triggered by Ca 2+ signaling, is involved in the regulation of cell proliferation and differentiation (19) (20) . ERK1/2 is an important component in the osteogenic action of FSS (3, 4, 18) . There is evidence that crosstalk exists between various signaling pathways, and that the activation of Ca 2+ signaling and ERK1/2 are important downstream events of a number of these pathways (3, (14) (15) 17, (21) (22) (23) (24) (25) . Therefore, the present study investigated how FSS affected the proliferation and differentiation of osteoblasts in the G0/G1 phase, with emphasis on CaMK II and ERK1/2.
Materials and methods
Reagents. The reagents used in the present study were obtained from the following sources: MC3T3-E1 subclone 14 were from the American Type Culture Collection (Manassas, VA, USA; cat. no. CRL-2594); α-minimum essential medium (MEM) was from Hyclone (GE Healthcare Life Sciences, Logan, UT, USA; cat. no. SH30265.01B); fetal bovine serum (FBS) was from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA; cat. no. 10082147); mouse anti-Runx2 (cat. no. ab76956), anti-collagen type I antibody (COLL I; cat. no. ab34710) and anti-osteocalcin antibody (OCN: cat. no. ab93876) were from Abcam (Cambridge, UK); rabbit anti-p21
Cip/Kip antibody was from Abcam (cat. no. ab109199); pRb (Ser780) rabbit monoclonal antibody was from Cell Signaling Technology, Inc. (Danvers, MA, USA; cat. no. D59B7); rabbit anti-p-ERK1/2 antibody was from Cell Signaling Technology, Inc. (cat. no. 14474); rabbit anti-CaMKII-α antibody (cat. no. ab50202), rabbit anti-CaMKII-γ antibody (cat. no. ab37999) and mouse anti-β-actin antibody (cat. no. ab6276) were all from Abcam. KN93 was obtained from Calbiochem (Merck KGaA, Darmstadt, Germany) and was dissolved in dimethyl sulfoxide. U0126 was obtained from Sigma-Aldrich (Merck KGaA). The alkaline phosphatase (ALP) activity kit (cat. no. A059-2) and ALP staining kit (cat. no. D001) were from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Bromodeoxyuridine (BrdU; cat. no. 11467229001) was from Roche Diagnostics GmbH (Mannheim, Germany). Trypsin and EDTA were from Irvine Scientific (Santa Ana, CA, USA).
Cell culture and G0/G1 phase arrest. The osteoblastic cell line MC3T3-E1 was cultured in α-MEM with 10% FBS, 100 U/ml penicillin and 100 g/ml streptomycin. Cells were maintained in a humidified incubator at 37˚C with 5% CO 2 and were subcultured every 48 h. For the FSS experiments, 50,000 cells were seeded onto glass slides. Cell cycle arrest at the G0/G1 phase was achieved by serum deprivation. Cells were washed three times with PBS and cultured in serum-free α-MEM for 24 h. Fluid shear experiments were performed 3 days subsequently, when cells were 75-80% confluent and G0/G1-arrested. The flow medium consisted of α-MEM containing 2% FBS, 100 U/ml penicillin and 100 g/ml streptomycin.
FSS experiment.
Fluid flow was applied to cells in a parallel plate flow chamber using a closed flow loop. The system used a constant hydrostatic pressure head to drive media through the channel of the flow chamber, to subject the cell monolayer to steady laminar flow resulting in a well-defined FSS of 12 dyne/cm 2 . The apparatus was maintained at 37˚C throughout the duration of experimentation. The correlation between FSS and flow rate was calculated using the equation:
where Q is the flow rate (cm 3 /s), µ is the viscosity of the flow media (0.01 dynes/cm 2 ), h is the height of the channel (0.022 cm), b is the slit width (3.2 cm), and τ is the wall shear stress (dyne/cm 2 ). A programmable Harvard Syringe Pump (PHD programmable; Harvard Apparatus, Holliston, MA, USA) was used to perfuse the flow chamber with fresh media at the aforementioned shear rate of 12 dyne/cm 2 .
BrdU assay. The BrdU ELISA (Amersham Cell Proliferation Biotrak ELISA system, version 2; cat. no. 11647229001; GE Healthcare Life Sciences, Little Chalfont, UK) is based on the incorporation of BrdU during DNA synthesis in proliferating cells. Prior to labeling, cells were seeded at a density of 50,000/ml in 96-well plates. In order to quantify the cell proliferation, 10 µM BrdU labeling reagent was added to each well (100 µl/well) and the cells were incubated for 2-12 h in a humidified incubator at 37˚C with 95% air and 5% CO 2 .
(Following stimulation, the DNA of MC3T3 cells will be duplicated during the first 12 h. Thus, the times points of 2-12 h were selected to identify the cell proliferation rate.) The BrdU labeling reagent was removed from the wells and 200 µl FixDenat solution (for cell fixation and DNA denaturation) was added, and the cells were incubated for 30 min at 15-25˚C. The FixDenat solution was removed, 100 µl/well anti-BrdU-POD working solution was added and the cells were incubated for 90 min at 15-25˚C. The antibody conjugate was removed and the wells were rinsed three times with 200-300 µl/well washing solution. The washing solution was subsequently removed and 100 µl/well substrate solution was added, followed by incubation at 15-25˚C until color development was sufficient for photometric detection (5-30 min). The reaction was stopped by adding 25 µl 2 M H 2 SO 4 solution to each well. The optical density (absorbance) of 150 µl of the resultant yellow-colored solution was read at 450 nm in a 96-well microplate spectrophotometer. The absorbance values correlated directly with the amount of DNA synthesis and thereby to the number of proliferating cells in culture.
ALP activity and staining. Cells were washed with PBS and frozen (-70˚C) in 300 ml Tris-Triton (0.1 M Tris-base; 0.2% TritonX-100). Following thawing, the cells were centrifuged (13,800 x g for 5 min at 4˚C) and the supernatant was used for analysis. ALP substrate was added to supernatant at a ratio of 1:1, and then the mixture was incubated at 37˚C for 40 min. Then 5 g/l NaOH was added to stop the reaction and the OD value detected at a wavelength of 410 nm. ALP activity was normalized to the total protein content. ALP staining was performed using the ALP staining kit, according to the manufacturer's protocol. The staining of ALP was observed by an inverted microscope (Leica Microsystems GmbH, Wetzlar, Germany).
Flow cytometry. MC3T3 cells were pelleted and fixed with 70% ethanol at 4˚C for 2 min. After the cells were digested with RNase, the DNA was stained with propidium iodide at 4˚C for 30 mins in the dark, and then analyzed with a flow cytometer (FACSCalibur, BD). CytExpert version 1.2.11.0 (Beckman Coulter, Inc., Brea, CA, USA) was used for date analysis.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis.
Total RNA was isolated from cells using the RNA Easy kit (Takara Biotechnology Co., Ltd., Dalian, China). RT was performed using a Prime Script™ RT reagent kit (Takara Biotechnology Co., Ltd.). qPCR assays were performed using SYBR Premix Ex Taq™ (Takara Biotechnology Co., Ltd.) and the ABI Prism 7900 sequence detection system (Shanghai Ying Huai Jie Trading Co. Ltd., Shanghai, China) for quantitation. The RT reactions were performed with the following cycling conditions: 95˚C for 30 sec, followed by 40 cycles of 95˚C for 5 sec and 56˚C for 30 sec. The gene expression was normalized to β-actin gene expression. The 2 -ΔΔCq method was used for normalization (26) . Each sample was analyzed in triplicate, in a total volume of 20 µl amplification mixture containing 10 µl SYBR Premix Ex Taq™ Mix (2X), 2 µl cDNA, 0.8 of each primer, 0.4 µl Rox I and 6 µl of H 2 O. Thermal cycling was performed by denaturation at 95˚C for 5 min, followed by 40 cycles of 95˚C for 5 sec and 60˚C for 30 sec (annealing). All primer sequences are presented in Table I .
Western blot analysis. ERK, p-ERK, CaMK II α and γ, OCN, COLL I, Runx2, pRb (S780) and the cell cycle marker p21
Cip/Kip in MC3T3 cells were analyzed by western blotting. For inhibition of ERK and CaMK II by U0126 and KN93, 10 µM KN93 or U0126 were added into a-MEM with 10% FBS for 12 h following FSS stimulation. Following treatment, cells were washed by PBS (4˚C) 3 times, then lysed by 200 µl RIPA (Beyotime Biotechnology Research Institute, P0013B) for 5 mins on ice. The cells were centrifuged (16, 200 x g for 25 min at 4˚C) and the supernatant was used for analysis. The concentration of the protein was determined by a BCA kit (NCI3227CH; Thermo Fisher Scientific, Inc.). Equal amounts of total cellular protein (30 µg per lane) were separated via 10% of the SDS-PAGE gel, and then electrotransferred to polyvinylidene difluoride membranes (Immobilon-P; EMD Millipore, Billerica, MA, USA) at 340 mA for 65 mins. Blots were incubated with a 1:1,000 dilution of each primary antibody overnight at 4˚C. Primary antibody binding was detected using a secondary antibody conjugated to horseradish peroxidase with a 1:5,000 dilution for 1 h at room temperature, and enhanced using an enhanced chemiluminescence assay kit (Amersham; GE Healthcare Life Sciences), according to the manufacturer's protocol. Chemiluminescence was imaged on a FUJIFILM LAS-3000 system (Fujifilm Holdings Corporation, Tokyo, Japan). Image Reader LAS 3000 (Fujifilm Holdings Corporation, Tokyo, Japan) was used for densitometric analysis. The basal levels of proteins were normalized to the level of β-actin protein.
Statistical analysis. All data are expressed as the mean ± standard deviation. Statistical analyses were performed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). A one-way analysis of variance with Duncan's multiple range test was used to examine the differences between groups. P<0.05 was considered to indicate a statistically significant difference.
Results
Fluid shear stress in the G0/G1 phase promotes osteoblast differentiation. In order to determine the response of osteoblasts induced by FSS, MC3T3-E1 cells in the G0/G1 phase were subjected to 12 dyne/cm 2 FSS for 1 h, and subsequently cultured in α-MEM containing 10% FBS for a further 24 h. Cell differentiation was determined by analysis of ALP activity and by ALP staining. Compared with the control, FSS significantly increased ALP activity by 28% (Fig. 1A and B) .
Runx2, which promotes the transcription of differentiated genes, is an important indicator of cell differentiation induced by FSS (27) . OCN and COLL I, which are transcriptionally-regulated by Runx2, are two early markers of osteoblast differentiation. The results of the present study demonstrated that OCN, COLL I and Runx2 mRNA expression was elevated by 5.59, 4.05 and 7.16-fold, respectively (Fig. 1C) . In addition, OCN, COLL I and Runx2 protein levels were upregulated by FSS (Fig. 1D) .
The results of the present study indicated that FSS promoted osteoblast differentiation in the G0/G1 phase.
FSS arrests the cell cycle at the G0/G1 phase. Following exposure to FSS, the DNA content of cells was decreased by 11.9% Table I 
Gene
Forward primer Reverse primer
COLL I, collagen type I; OCN, osteocalcin; Runx2, runt-related transcription factor 2.
compared with the control (Fig. 2A) . The percentage of cells in the S phase decreased to 6.46% compared with the control value of 16.34% ( Fig. 2B and C) . The results indicated that FSS inhibited proliferation through inhibition of the transition between the G0/G1 and S phases.
Promotion of osteoblast differentiation induced by FSS in the G0/G1 phase is associated with CaMK II and the ERK1/2 signaling pathway.
CaMK II and ERK1/2 have been reported to regulate osteoblast differentiation induced by FSS (28) . The present study further investigated the potential involvement of ERK1/2 and CaMK II during FSS-induced differentiation in the G0/G1 phase (Fig. 3) . Western blotting demonstrated that both ERK1/2 and p-ERK1/2 in MC3T3-E1 cells increased following stimulation with FSS (Fig. 3A) . Among the four isoforms of CaMKII, only CaMK II-α and -γ have been observed to be expressed in osteoblasts, and CaMK II-α is involved in differentiation (20) . The results of the present study demonstrated that the expression of CaMK II-α was increased following stimulation with FSS, while CaMK II-γ was not significantly different between the control and FSS groups (Fig. 3A) . In addition, FSS increased Runx2 activity, and the induction of Runx2 was accompanied by an increase in ALP activity and the expression of OCN and COLL I (Fig. 1) .
To ascertain whether the CaMK II or ERK1/2 pathways mediated osteoblast differentiation in response to FSS, KN93, an inhibitor of CaMK II, and U0126, an inhibitor of ERK1/2, were used to treat the cells. The results of the present study demonstrated that the induction of Runx2 by FSS was partially inhibited when CaMK II or ERK1/2 was inhibited ( Fig. 3E and F) . It was additionally observed that treatment with KN93 and U0126 in the presence of FSS abolished ALP activity, and the transcription and expression of OCN and COLL I (Fig. 3B-D and F) . The present results indicated that the CaMK II and ERK1/2 signaling pathways were necessary for osteoblast differentiation induced by FSS.
ERK1/2, not CaMK II, mediates FSS-induced p21
Cip/Kip upregulation and pRb dephosphorylation. Induction of the cell cycle regulator p21
Cip/Kip is an important indicator of ERK1/2-induced inhibition of proliferation (29) (30) (31) (32) . In the present study, FSS increased p21
Cip/Kip (Fig. 4A ), ERK1/2 and p-ERK1/2 activity (Fig. 3A) . The induction of p21
Cip/Kip was accompanied by pRb dephosphorylation and an 11.82% decrease in the number of proliferating cells (Fig. 4B) .
To ascertain whether ERK1/2 mediated p21 Cip/Kip induction and MC3T3 cell proliferation in response to FSS, the effect the presence of FSS increased cell numbers (Fig. 4B) and S phase re-entry ( Fig. 4C and D) , compared with the FSS group. The present results indicated that FSS inhibited MC3T3 cell proliferation, in part through the ERK1/2-p21
Cip/Kip signaling pathway.
Although CaMK II mediated the differentiation of MC3T3 cells exposed to FSS, the induction of p21
Cip/Kip by FSS was not decreased when cells were pretreated with KN93. Additionally, the inhibition of CaMK II during FSS stimulation did not increase cell numbers (Fig. 4B ) compared with the FSS group. The results indicated that CaMK II was not implicated in the proliferation inhibited by FSS.
Discussion
Previous studies reported that FSS promoted the proliferation and differentiation of osteoblasts. However, the conditions of osteoblast proliferation and differentiation induced by FSS have rarely been reported. Proliferation and differentiation are exclusive cellular events. Cells enter into the cell cycle to commence proliferation, whereas cells exit the cell cycle prior to differentiation. Therefore, the present study investigated the effects of FSS on osteoblast-like MC3T3 cells in the G0/G1 phase, the period during which cell proliferation or differentiation is determined. It was observed that FSS in the G0/G1 phase promoted the differentiation of MC3T3 cells through the ERK1/2 and CaMK II signaling pathways, and partly arrested the cell cycle at the G0/G1 phase via the ERK1/2 pathway. The results of the present study provided evidence for the fact that proliferation and differentiation may not be promoted by FSS simultaneously, and demonstrated the necessity of further research to elucidate the mechanobiology of the effect of FSS on osteoblasts.
Loading of bone causes movement of interstitial fluid within bone. Bone exhibits the unique ability to modify its structure via bone-associated cells in response to fluid flow. Previous studies have focused on how the cells, including osteoblasts, respond to FSS (3) (4) (5) . Although certain studies noted that FSS promoted osteoblast proliferation or differentiation (33, 34) , further details of the process were not reported. Proliferation and differentiation are distinct cellular events that occur at different cell stages. Therefore, further studies using different cell populations induced by FSS are required. In the present study, in order to demonstrate when FSS altered the differentiation or proliferation of osteoblasts, osteoblasts at the G0/G1 phase, the period during which cell differentiation or entry into the cell cycle is determined, were obtained and the roles of FSS were investigated. The results of the present study demonstrated that FSS decreased the cell numbers, although it increased the expression of Runx2, COLL I and OCN, which are markers of osteoblast differentiation. The results of the present study demonstrated that FSS during the G0/G1 phase induced the differentiation of osteoblasts while arresting the cell cycle at the G0/G1 phase.
It has been reported that osteoblasts express Runx2 in the G0/G1 phase. Runx2 is important for the differentiation of osteoblasts (35) (36) (37) (38) , and is able to directly stimulate the transcription of osteoblast-associated genes, including ALP, COLL I and OCN, by binding to specific enhancer regions (19,39,40) . The results of the present study demonstrated that FSS induced an increase in Runx2 expression, which indicated that FSS promoted Runx2 activity in MC3T3 cells. It was hypothesized that Runx2 may be an important factor enabling FSS to promote the differentiation of osteoblasts in the G0/G1 phase. The results of the present study demonstrated that the increase in Runx2 activity was accompanied by activation of CaMK II α and ERK1/2. Additionally, the inhibition of CaMK II or ERK1/2 decreased the protein level of Runx2, and reduced ALP activity and the expression of OCN and COLL I. The combination of KN93 and U0126 inhibited the expression of FSS-induced differentiation markers. Previous studies have reported that CaMK II and ERK1/2 may be involved in regulating proliferation and differentiation (29) (30) (31) 41, 42) . Inhibition of ERK1/2 by U0126 and CaMK II by KN93 decreased FSS-induced Runx2 activity, indicating that Runx2 was the downstream regulator of ERK1/2 and CaMK II in osteoblast differentiation induced by FSS in the G0/G1 phase. The results of the present study demonstrated that FSS in the G0/G1 phase promoted the differentiation of osteoblasts by enhancing the protein level of Runx2 via the CaMK II and ERK1/2 signaling pathways.
The notable markers of proliferative inhibition are pRb dephosphorylation and G0/G1 phase arrest. p21
Cip/Kip , which inhibits pRb phosphorylation (43) (44) (45) , has been reported to inhibit proliferation in different cell types (35, 46, 47) . Runx2 interacts with pRb (9,10) and the overexpression of Runx2 suppresses proliferation and causes a delay in the G1 phase of MC3T3 preosteoblasts (27) . It was considered that increased expression of Runx2 induced by FSS may be associated with pRb regulation, which was necessary for S phase entry. Notably, the results of the present study demonstrated that the high expression of Runx2 induced by FSS was accompanied by pRb dephosphorylation and an upregulation of p21 Cip/Kip . In addition, the present study investigated whether CaMK II and ERK1/2 were involved in cell cycle regulation. It was observed that inhibition of ERK1/2 by U0126 increased cell numbers and S phase re-entry. However, inhibition of ERK1/2 in static control only partially inhibited cell entry into S phase. The ERK1/2 pathway has been demonstrated to be involved in the positive and negative regulation of cell growth (29) (30) (31) . The results of the present study demonstrated that ERK1/2 induced by FSS primarily exerted negative regulation of the cell cycle. An additional signaling pathway, CaMK II, was observed to be irrelevant to cell cycle induction by FSS. The CaMK II pathway has been reported to be a stimulus for cell proliferation (34, 42) . The present findings indicated that inhibition of CaMK II reduced cells numbers in static control, in accordance with these previous studies. The results of the present study demonstrated that CaMK II was not involved in the FSS-induced inhibition of S phase entry. Another notable feature of MC3T3 cells in the G0/G1 phase is the increased expression of p21
Cip/Kip activity (27) . The present study investigated the role of the ERK1/2 and CaMK II signaling pathways in p21
Cip/Kip regulation. It was observed that FSS promoted p21
Cip/Kip activity in MC3T3 cells. Inhibition of ERK1/2 by U0126 suppressed p21
Cip/Kip activity induced by FSS, although inhibition of CaMK II had little effect on p21 Cip/Kip . Previous studies have reported that the inhibition of CaMK II induced p21
Cip/Kip activity, which was mediated by cell proliferation in other cell types (45,48,49) .
However, the results of the present study demonstrated that CaMK II was not involved in p21
Cip/Kip expression induced by FSS in MC3T3 cells.
In conclusion, in the present study, we found that in the G0/G1 phase, FSS promoted osteoblast differentiation via the CaMK II and ERK1/2 signaling pathways although it inhibited proliferation via the ERK1/2-p21 pathway only. The present findings provided a deeper understanding of the mechanism underlying osteoblastic mechanobiology.
